5 Tips about Clinical effectiveness of ABBV-744 in AML patients You Can Use Today
In Phase C, members will receive ABBV-744 and oral navitoclax. In Section D, members will acquire ABBV-744 and ruxolitinib. Individuals will get treatment until disorder progression or even the members are unable to tolerate the study drugs.Celastrol was identified like a Myb inhibitor that suppressed C/EBPβ action and repressed AML cell prolifera